Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

A multiple ligand-binding radioimmunoassay of diiodotyrosine.
J C Nelson, … , R B Wilcox, F J Palmer
J C Nelson, … , R B Wilcox, F J Palmer
Published February 1, 1974
Citation Information: J Clin Invest. 1974;53(2):416-422. https://doi.org/10.1172/JCI107575.
View: Text | PDF
Research Article

A multiple ligand-binding radioimmunoassay of diiodotyrosine.

  • Text
  • PDF
Abstract

A radioimmunoassay has been developed for the measurement of 3,5-diiodo-L-tyrosine (DIT) in serum. DIT was coupled to porcine thyroglobulin (PTg) with a molar ratio of 205:1. Rabbits were immunized with 1 mg of immunogen emulsified in complete Freund's adjuvant. Sera were screened for their ability to bind trace amounts of [125I]DIT. A serum that bound 40% of the tracer at a final dilution of 1:1,750 was used in the assay. Assay specificity was improved by the use of thyroxine (T4)-binding globulin as a second ligand-binding protein to decrease T4 and triiodothyronine (T3) cross-reactivity with the antibody. Double antibody and polyethylene glycol radioimmunoassays were compared. DIT present in the second antiserum shifted the double antibody assay standard curve and altered estimates of assay specificity and assay sensitivity. By using the polyethylene glycol system and butanol:ethanol extracts of serum, DIT was measured in human serum. In 35 apparently healthy young adult controls DIT levels averaged 156 ng/100 ml. Random DIT levels averaged 158 ng/100 ml in 11 untreated hyperthyroid patients and 84 ng/100 ml in 15 untreated primary hypothyroid patients. No diurnal pattern in DIT levels could be demonstrated. Thyroid-stimulating hormone administration led to a variable but small rise in DIT levels, but short term T3 suppression was not associated with a measurable fall in DIT concentrations. Paired serum samples from the carotid artery and thyroid vein of 10 euthyroid goiter patients and one patient with a toxic solitary adenoma all showed a positive transthyroidal gradient indicating the thyroidal release of DIT in each patient. Measurable DIT levels of 45, 47, 68, and 80 ng/100 ml, respectively, were found in four fasting athyrotic patients indicating that the thyroid is not the only source of serum DIT.

Authors

J C Nelson, R M Weiss, J E Lewis, R B Wilcox, F J Palmer

×

Total citations by year

Year: 1987 1986 1984 1983 1981 1978 1977 1976 1975 1974 Total
Citations: 1 1 1 1 1 1 2 1 1 1 11
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (11)

Title and authors Publication Year
Radioimmunoassay in Basic and Clinical Pharmacology
C Patrono, BA Peskar
1987
Clinical Endocrinology
A Labhart
Clinical Endocrinology 1986
Clinical Biochemistry
E Cooper, M Bowen
Clinical Biochemistry 1984
3,5-diiodotyrosine excretion in human urine in individuals of differing thyroidal status
MN Mohammed, M Farmer, DB Ramsden
Biological Mass Spectrometry 1983
Changes in thyroidal and plasma lodine compounds during and after metamorphosis of the bullfrog, Rana catesbeiana
S Suzuki, M Suzuki
General and Comparative Endocrinology 1981
Klinik der inneren Sekretion
A Labhart
1978
THE ACTION OF THYROID HORMONE
J Bernal, S Refetoff
Clinical Endocrinology 1977
Thyroid cancer classification, clinical features, diagnosis and therapy
AJ van Herle, RP Uller
Pharmacology & Therapeutics Part C Clinical Pharmacology and Therapeutics 1977
Binding of 3,5-diiodotyrosine to serum proteins
J Bismuth, M Castay, S Lissitzky
Clinica Chimica Acta 1976
Radioimmunoassay and the hormones of thyroid function
TJ Stahl
Seminars in Nuclear Medicine 1975
Mass spectrometric studies of thyroxine and related compounds. Trimethylsilyl derivatives
AM Lawson, DB Ramsden, PJ Raw, R Hoffenberg
Biological Mass Spectrometry 1974

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts